150 related articles for article (PubMed ID: 1666697)
1. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
Söderbäck U; Sollevi A
Thromb Res; 1991 Nov; 64(3):355-62. PubMed ID: 1666697
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
[TBL] [Abstract][Full Text] [Related]
4. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
Mills DC; Smith JB
Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
[TBL] [Abstract][Full Text] [Related]
5. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Mar; 72(3):443-7. PubMed ID: 7260485
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
Cooper JA; Hill SJ; Alexander SP; Rubin PC; Horn EH
Br J Clin Pharmacol; 1995 Jul; 40(1):43-50. PubMed ID: 8527267
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.
Nakamura T; Uchiyama S; Yamazaki M; Iwata M
Thromb Res; 2007; 119(4):511-6. PubMed ID: 17046050
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
Peakman MC; Hill SJ
Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evidence of a specific adenosine A2/Ra receptor on human platelets.
Quattrin S; Genovese A; Cirillo R; Formisano S; Marone G
Ric Clin Lab; 1988; 18(2-3):105-18. PubMed ID: 2850603
[TBL] [Abstract][Full Text] [Related]
10. Interplay between milrinone and adenosine in the inhibition of human platelet response.
Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M
Gen Pharmacol; 1996 Oct; 27(7):1149-54. PubMed ID: 8981060
[TBL] [Abstract][Full Text] [Related]
11. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex.
Bazil CW; Minneman KP
J Neurochem; 1986 Aug; 47(2):547-53. PubMed ID: 3016175
[TBL] [Abstract][Full Text] [Related]
13. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
Agarwal KC; Buckley RS; Parks RE
Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
[TBL] [Abstract][Full Text] [Related]
14. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory mechanism of dipyridamole on platelet aggregation ex vivo.
Fukawa K; Saitoh K; Irino O; Ohkubo K; Hashimoto S
Thromb Res; 1982 Aug; 27(3):333-40. PubMed ID: 6291192
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
Azuma H; Takashima Y; Ishikawa M; Yamakado T
Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
[TBL] [Abstract][Full Text] [Related]
20. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
Subbarao K; Rucinski B; Niewiarowski S
Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
